2nd Quarter - Report

GALILEO CONSULTING GROUP, INC. for SONOSITE, A SUBSIDIARY OF FUJIFILM (FORMERLY SONOSITE, INC.)

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-- S. 3187 - Food and Drug Administration Safety and Innovation Act: Reauthorization of medical device user fees at the Food and Drug Administration (FDA) (MDUFA); reauthorization of the Accredited Persons Program (Third Party Review Program) within the FDA. -- H.R. 2104 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 / S. 3338 - Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2012: Legislation to amend the Public Health Service Act to require personnel who perform or plan the technical component of either medical imgaing examinations or radiation therapy procedures for medical purposes to possess certain certification or licensure, effective January 1, 2014, and for other purposes.

LobbyistCovered position, as disclosed
JILL RATHBUN —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3187 (112th), S. 3338 (112th), H.R. 2104 (112th)

Medicare/Medicaid MMM

-- Support preservation of Medicare reimbursement for ultrasound procedures. -- Promote ultrasound services as a means to lower Medicare costs and increase patient safety.

LobbyistCovered position, as disclosed
JILL RATHBUN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
FUJIFILM HOLDINGS CORPORATION Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.